Phase I trial of concurrent chemo radiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).

被引：0
|
作者：
Katori, H [1 ]
Tsukuda, M [1 ]
Ishitoya, J [1 ]
Mikami, Y [1 ]
Matsuda, H [1 ]
Tanigaki, Y [1 ]
Horiuchi, C [1 ]
Ikeda, Y [1 ]
Ono, M [1 ]
Hirose, S [1 ]
机构：
[1] Yokohama City Univ, Yokohama, Kanagawa 232, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5560
引用
收藏
页码：503S / 503S
页数：1
相关论文
共 50 条
  • [1] Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Katori, H
    Tsukuda, M
    Mochimatu, I
    Ishitoya, J
    Kawai, S
    Mikami, Y
    Matsuda, H
    Tanigaki, Y
    Horiuchi, C
    Ikeda, Y
    Taguchi, T
    Ono, M
    Yoshida, T
    Hirose, S
    Sakuma, Y
    Yamamoto, K
    BRITISH JOURNAL OF CANCER, 2004, 90 (02) : 348 - 352
  • [2] Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    H Katori
    M Tsukuda
    I Mochimatu
    J Ishitoya
    S Kawai
    Y Mikami
    H Matsuda
    Y Tanigaki
    C Horiuchi
    Y Ikeda
    T Taguchi
    M Ono
    T Yoshida
    S Hirose
    Y Sakuma
    K Yamamoto
    British Journal of Cancer, 2004, 90 : 348 - 352
  • [3] Concurrent Chemoradiotherapy with Docetaxel, Cisplatin and 5-Fluorouracil (TPF) in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck
    Komatsu, Masanori
    Shiono, Osamu
    Taguchi, Takahide
    Sakuma, Yasunori
    Nishimura, Goushi
    Sano, Daisuku
    Sakuma, Naoko
    Yabuki, Kenichiro
    Arai, Yasuhiro
    Takahashi, Masahiro
    Isitoya, Junichi
    Oridate, Nobuhiko
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (05) : 416 - 421
  • [4] Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Katori, Hideaki
    Tsukuda, Mamoru
    Watai, Kiichi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (03) : 399 - 406
  • [5] Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Hideaki Katori
    Mamoru Tsukuda
    Kiichi Watai
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 399 - 406
  • [6] Adjuvant docetaxel, cisplatin and 5-Fluorouracil (TPF) in locally advanced squamous cell carcinoma of the head and neck
    Baghi, M
    Hambek, M
    May, A
    Radeloff, A
    Gstoettner, W
    Knecht, R
    ANTICANCER RESEARCH, 2006, 26 (1B) : 559 - 563
  • [7] Comparison of induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (TPF) followed by radiation versus concurrent chemoradiotherapy with TPF in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Katori, R
    Tsukuda, M
    Ishitoya, J
    Kimura, M
    Hirose, S
    Takahashi, M
    Sakuma, Y
    Yamamoto, K
    Satoh, N
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 519S - 519S
  • [8] Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Katori, Hideaki
    Tsukuda, Mamoru
    Watai, Kiichi
    ANNALS OF ONCOLOGY, 2006, 17 : 181 - 181
  • [9] Phase I trial of combined chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for patients with locally advanced squamous cell carcinoma of the head and neck
    Tsukuda M.
    Mikami Y.
    Tanigaki Y.
    Katori H.
    Horiuchi C.
    Ikeda Y.
    Taguchi T.
    Ono M.
    Yoshida T.
    Sakuma Y.
    Aikoh K.
    International Journal of Clinical Oncology, 2004, 9 (3) : 161 - 166
  • [10] A phase II trial of docetaxel, cisplatin and 5-fluorouracil in patients with recurrent squamous cell carcinoma of the head and neck (SCCHN)
    Baghi, M
    Hambek, M
    Wagenblast, J
    May, A
    Wolfgang
    Gstoettner
    Knecht, R
    ANTICANCER RESEARCH, 2006, 26 (1B) : 585 - 590
12345